Evaluation of effects caused by differentially spliced Ets-1 transcripts in fibroblasts

International Journal of Oncology

Volumn 39, Issue 5, 2011, Pages 1073-1082

  Hahne, Jens Claus ^a   Fuchs, Tanja ^b   Florin, Alexandra ^b   Edwards, Dylan ^c   Pourtier, Albin ^d,e,f   Soncin, Fabrice ^d,e,f   Wernert, Nicolas ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d UNIV LILLE   (France)

^e CNRS   (France)

^f UNITÉ DE CATALYSE ET DE CHIMIE DU SOLIDE   (France)

Author keywords

Cytokine; Ets 1; Fibroblast; Metalloproteinases; Splice variant; Tissue inhibitors of metalloproteinases

Indexed keywords

COLLAGENASE 3; GELATINASE B; PROTEIN P42; PROTEIN P51; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TRANSCRIPTION FACTOR ETS 1;

ANIMAL CELL; ARTICLE; CELL LINE; EVALUATION; FIBROBLAST; GENE OVEREXPRESSION; GENE TARGETING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DNA BINDING; PROTEIN EXPRESSION; RNA INTERFERENCE;

ALTERNATIVE SPLICING; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; FIBROBLASTS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INTRACELLULAR SPACE; MICE; NIH 3T3 CELLS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEIN C-ETS-1; TRANSCRIPTION, GENETIC;

EID: 80053216448     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2011.1152     Document Type: Article

References (56)

1. Adam M, Schmidt D, Wardelmann E, Wernert N and Albers P: Angiogenetic protooncogene ets-1 induced neovascularization is involved in the metastatic process of testicular germ cell tumors. Eur Urol 44: 329-336, 2003. (Pubitemid 37051701)
2. Grevin D, Chen JH, Raes MB, Stehelin D, Vandenbunder B and Desbiens X: Involvement of the proto-oncogene c-ets 1 and the urokinase plasminogen activator during mouse implantation and placentation. Int J Dev Biol 37: 519-529, 1993. (Pubitemid 24063753)
3. Khatun S, Fujimoto J, Toyoki H and Tamaya T: Clinical implications of expression of ETS-1 in relation to angiogenesis in ovarian cancers. Cancer Sci 94: 769-773, 2003. (Pubitemid 37258774)
4. Pourtier-Manzanedo A, Vercamer C, Van Belle E, Mattot V, Mouquet F and Vandenbunder B: Expression of an Ets-1 dominant-negative mutant perturbs normal and tumor angiogenesis in a mouse ear model. Oncogene 22: 1795-1806, 2003. (Pubitemid 36513139)
5. Vandenbunder B, Pardanaud L, Jaffredo T, Mirabel MA and Stehelin D: Complementary patterns of expression of c-ets 1, c-myb and c-myc in the blood-forming system of the chick embryo. Development 107: 265-274, 1989. (Pubitemid 19283401)
6. Wernert N, Gilles F, Fafeur V, Bouali F, Raes MB, Pyke C, Dupressoir T, Seitz G, Vandenbunder B and Stehelin D: Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. Cancer Res 54: 5683-5688, 1994. (Pubitemid 24346267)
7. Wernert N, Raes MB, Lassalle P, Dehouck MP, Gosselin B, Vandenbunder B and Stehelin D: c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am J Pathol 140: 119-127, 1992.
8. Behrens P, Mathiak M, Mangold E, Kirdorf S, Wellmann A, Fogt F, Rothe M, Florin A and Wernert N: Stromal expression of invasion-promoting, matrix-degrading proteases MMP-1 and -9 and the Ets 1 transcription factor in HNPCC carcinomas and sporadic colorectal cancers. Int J Cancer 107: 183-188, 2003. (Pubitemid 37152895)
9. Behrens P, Rothe M, Florin A, Wellmann A and Wernert N: Invasive properties of serous human epithelial ovarian tumors are related to Ets-1, MMP-1 and MMP-9 expression. Int J Mol Med 8: 149-154, 2001.
10. Behrens P, Rothe M, Wellmann A, Krischler J and Wernert N: The Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J Pathol 194: 43-50, 2001.
11. Wernert N: The multiple roles of tumour stroma. Virchows Arch 430: 433-443, 1997.
12. Westermarck J and Kahari VM: Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13: 781-792, 1999. (Pubitemid 29220691)
13. Hahne JC, Okuducu AF, Kaminski A, Florin A, Soncin F and Wernert N: Ets-1 expression promotes epithelial cell transformation by inducing migration, invasion and anchorage-independent growth. Oncogene 24: 5384-5388, 2005. (Pubitemid 43080108)
14. Wasylyk B, Hahn SL and Giovane A: The Ets family of transcription factors. Eur J Biochem 211: 7-18, 1993. (Pubitemid 23039491)
15. Baker KM, Wei G, Schaffner AE and Ostrowski MC: Ets-2 and components of mammalian SWI/SNF form a repressor complex that negatively regulates the BRCA1 promoter. J Biol Chem 278: 17876-17884, 2003. (Pubitemid 36799393)
16. Maurer P, T'Sas F, Coutte L, Callens N, Brenner C, Van Lint C, de Launoit Y and Baert JL: FEV acts as a transcriptional repressor through its DNA-binding ETS domain and alanine-rich domain. Oncogene 22: 3319-3329, 2003. (Pubitemid 36712944)
17. Meraro D, Gleit-Kielmanowicz M, Hauser H and Levi BZ: IFN-stimulated gene 15 is synergistically activated through interactions between the myelocyte/lymphocyte-specific transcription factors, PU.1, IFN regulatory factor-8/IFN consensus sequence binding protein, and IFN regulatory factor-4: characterization of a new subtype of IFN-stimulated response element. J Immunol 168: 6224-6231, 2002. (Pubitemid 34620042)
18. Sgouras DN, Athanasiou MA, Beal GJ, Fisher RJ, Blair DG and Mavrothalassitis GJ: ERF: an ETS domain protein with strong transcriptional repressor activity, can suppress ets-associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation. EMBO J 14: 4781-4793, 1995.
19. Soudant N, Albagli O, Dhordain P, Flourens A, Stehelin D and Leprince D: A residue of the ETS domain mutated in the v-ets oncogene is essential for the DNA-binding and transactivating properties of the ETS-1 and ETS-2 proteins. Nucleic Acids Res 22: 3871-3879, 1994. (Pubitemid 24310096)
20. Starck J, Cohet N, Gonnet C, Sarrazin S, Doubeikovskaia Z, Doubeikovski A, Verger A, Duterque-Coquillaud M and Morle F: Functional cross-antagonism between transcription factors FLI-1 and EKLF. Mol Cell Biol 23: 1390-1402, 2003. (Pubitemid 36177047)
21. Waga K, Nakamura Y, Maki K, Arai H, Yamagata T, Sasaki K, Kurokawa M, Hirai H and Mitani K: Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells. Oncogene 22: 59-68, 2003. (Pubitemid 36152884)
22. Yang J, Shultz RW, Mars WM, Wegner RE, Li Y, Dai C, Nejak K and Liu Y: Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. J Clin Invest 110: 1525-1538, 2002. (Pubitemid 35396923)
23. Hollenhorst PC, Jones DA and Graves BJ: Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors. Nucleic Acids Res 32: 5693-5702, 2004. (Pubitemid 39545685)
24. Mattot V, Vercamer C, Soncin F, Calmels T, Huguet C, Fafeur V and Vandenbunder B: Constitutive expression of the DNA-binding domain of Ets1 increases endothelial cell adhesion and stimulates their organization into capillary-like structures. Oncogene 19: 762-772, 2000. (Pubitemid 30107707)
25. Petersen JM, Skalicky JJ, Donaldson LW, McIntosh LP, Alber T and Graves BJ: Modulation of transcription factor Ets-1 DNA binding: DNA-induced unfolding of an alpha helix. Science 269: 1866-1869, 1995.
26. Jonsen MD, Petersen JM, Xu QP and Graves BJ: Characterization of the cooperative function of inhibitory sequences in Ets-1. Mol Cell Biol 16: 2065-2073, 1996. (Pubitemid 26123726)
27. Garvie CW, Pufall MA, Graves BJ and Wolberger C: Structural analysis of the autoinhibition of Ets-1 and its role in protein partnerships. J Biol Chem 277: 45529-45536, 2002. (Pubitemid 36159163)
28. Rabault B and Ghysdael J: Calcium-induced phosphorylation of ETS1 inhibits its specific DNA binding activity. J Biol Chem 269: 28143-28151, 1994. (Pubitemid 24354549)
29. Cowley DO and Graves BJ: Phosphorylation represses Ets-1 DNA binding by reinforcing autoinhibition. Genes Dev 14: 366-376, 2000. (Pubitemid 30106491)
30. Lionneton F, Lelievre E, Baillat D, Stehelin D and Soncin F: Characterization and functional analysis of the p42Ets-1 variant of the mouse Ets-1 transcription factor. Oncogene 22: 9156-9164, 2003. (Pubitemid 38067991)
31. Jorcyk CL, Watson DK, Mavrothalassitis GJ and Papas TS: The human ETS1 gene: genomic structure, promoter characterization and alternative splicing. Oncogene 6: 523-532, 1991. (Pubitemid 21924115)
32. Bellacosa A, Datta K, Bear SE, Patriotis C, Lazo PA, Copeland NG, Jenkins NA and Tsichlis PN: Effects of provirus integration in the Tpl-1/Ets-1 locus in Moloney murine leukemia virus-induced rat T-cell lymphomas: levels of expression, polyadenylation, transcriptional initiation, and differential splicing of the Ets-1 mRNA. J Virol 68: 2320-2330, 1994.
33. Koizumi S, Fisher RJ, Fujiwara S, Jorcyk C, Bhat NK, Seth A and Papas TS: Isoforms of the human ets-1 protein: generation by alternative splicing and differential phosphorylation. Oncogene 5: 675-681, 1990.
34. Fisher RJ, Fivash M, Casas-Finet J, Erickson JW, Kondoh A, Bladen SV, Fisher C, Watson DK and Papas T: Real-time DNA binding measurements of the ETS1 recombinant oncoproteins reveal significant kinetic differences between the p42 and p51 isoforms. Protein Sci 3: 257-266, 1994. (Pubitemid 24086358)
35. Huang CC, Papas TS and Bhat NK: A variant form of ETS1 induces apoptosis in human colon cancer cells. Oncogene 15: 851-856, 1997.
36. Li R, Pei H and Papas T: The p42 variant of ETS1 protein rescues defective Fas-induced apoptosis in colon carcinoma cells. Proc Natl Acad Sci USA 30: 3876-3881, 1999.
37. Graham FL and Van der Eb AJ: Transformation of rat cells by DNA of human adenovirus 5. Virology 54: 536-539, 1973.
38. Loyter A, Scangos GA and Ruddle FH: Mechanisms of DNA uptake by mammalian cells: fate of exogenously added DNA monitored by the use of fluorescent dyes. Proc Natl Acad Sci USA 79: 422-426, 1982. (Pubitemid 12137724)
39. Wadman IA, Osada H, Grutz GG, Agulnick AD, Westphal H, Forster A and Rabbitts TH: The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J 16: 3145-3157, 1997. (Pubitemid 27234954)
40. Jesnowski R, Backhaus C, Ringel J and Lohr M: Ribosomal highly basic 23-kDa protein as a reliable standard for gene expression analysis. Pancreatology 2: 421-424, 2002. (Pubitemid 34920733)
41. Hynes RO, Lively JC, McCarty JH, Taverna D, Francis SE, Hodivala-Dilke K and Xiao Q: The diverse roles of integrins and their ligands in angiogenesis. Cold Spring Harb Symp Quant Biol 67: 143-153, 2002. (Pubitemid 36775506)
42. Maroulakou IG, Papas TS and Green JE: Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis. Oncogene 9: 1551-1565, 1994. (Pubitemid 24163380)
43. Pardanaud L and Dieterlen-Lievre F: Expression of C-ETS1 in early chick embryo mesoderm: relationship to the hemangioblastic lineage. Cell Adhes Commun 1: 151-160, 1993.
44. Queva C, Leprince D, Stehelin D and Vandenbunder B: p54c-ets-1 and p68c-ets-1, the two transcription factors encoded by the c-ets-1 locus, are differentially expressed during the development of the chick embryo. Oncogene 8: 2511-2520, 1993. (Pubitemid 23252381)
45. Kola I, Brookes S, Green AR, Garber R, Tymms M, Papas TS and Seth A: The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc Natl Acad Sci USA 90: 7588-7592, 1993. (Pubitemid 23249995)
46. Vandenbunder B, Queva C, Desbiens X, Wernert N and Stehelin D: Expression of the transcription factor c-Ets1 correlates with the occurrence of invasive processes during normal and pathological development. Invasion Metastasis 14: 198-209, 1994.
47. Calmels TP, Mattot V, Wernert N, Vandenbunder B and Stehelin D: Invasive tumors induce c-ets1 transcription factor expression in adjacent stroma. Biol Cell 84: 53-61, 1995. (Pubitemid 26004111)
48. Anderson MK, Hernandez-Hoyos G, Diamond RA and Rothenberg EV: Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage. Development 126: 3131-3148, 1999. (Pubitemid 29378177)
49. Bories JC, Willerford DM, Grevin D, Davidson L, Camus A, Martin P, Stehelin D and Alt FW: Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature 377: 635-638, 1995.
50. Barton K, Muthusamy N, Fischer C, Ting CN, Walunas TL, Lanier LL and Leiden JM: The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity 9: 555-563, 1998. (Pubitemid 28499206)
51. Hahne JC, Fuchs T, El Mustapha H, Okuducu AF, Bories JC and Wernert N: Expression pattern of matrix metalloproteinase and TIMP genes in fibroblasts derived from Ets-1 knock-out mice compared to wild-type mouse fibroblasts. Int J Mol Med 18: 153-159, 2006.
52. Wang M, Liu YE, Greene J, Sheng S, Fuchs A, Rosen EM and Shi YE: Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4. Oncogene 14: 2767-2774, 1997. (Pubitemid 27313408)
53. Hilska M, Roberts PJ, Collan YU, Laine VJ, Kossi J, Hirsimaki P, Rahkonen O and Laato M: Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer. Int J Cancer 121: 714-723, 2007. (Pubitemid 47106199)
54. Guo YH, Gao W, Li Q, Li PF, Yao PY and Chen K: Tissue inhibitor of metalloproteinases-4 suppresses vascular smooth muscle cell migration and induces cell apoptosis. Life Sci 75: 2483-2493, 2004. (Pubitemid 39180052)
55. Yang CM, Luo SF, Hsieh HL, Chi PL, Lin CC, Wu CC and Hsiao LD: Interleukin-1beta induces ICAM-1 expression enhancing leukocyte adhesion in human rheumatoid arthritis synovial fibroblasts: involvement of ERK, JNK, AP-1, and NF-kappaB. J Cell Physiol 224: 516-526, 2010.
56. Jakus Z, Fodor S, Abram CL, Lowell CA and Mócasai A: Immunoreceptor-like signaling by beta 2 and beta 3 integrins. Trends Cell Biol 17: 493-501, 2007.